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Abstract Acute severe methemoglobinaemia is an uncom-
mon but life-threatening condition caused by a variety of
oxidizing agents commonly used in both health care and
industrial settings. Thus, recognition is important as it is
readily treatable. The oxygen transport is compromised as a
result of abnormal levels of oxidized haemoglobin, and this
leads to skin discolouration and a variety of symptoms.
Diagnostic confusion occurs as the oxygen saturations
(SpO2) on the pulse oximeter are unreliable (Sharma V,
Haber A. Acquired methaemoglobinaemia: a case report of
benzocaine-induced methaemoglobinaemia and a review of
the literature. Clin Pul Med. 2002;9(1):53–8). A case of
severe methaemoglobinaemia due to self poisoning with
barbicide is presented with a brief discussion of the patho-
physiology and an overview of the treatment. A barbicidal
overdose has never been reported before.
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Case report
A 53-year-old female was blue lighted into our emergency
department resuscitation room by ambulance crew as she
appeared extremely cyanotic from face to feet. She
complained of nausea, vomiting and difficulty in breathing.
Her most striking feature was a bluish hue of her face
(Fig. 1) including her lips and forearms. She looked as if
she had fallen onto blue ink and had some residual staining.
However, closer examination revealed that this discoloura-
tion was present throughout, including her nails (Fig. 2).
Oxygen therapy had made no difference to her appearance.
She appeared confused and was unable to give any coherent
history.
She was tachycardic (130/min) and tachypnoeic (30/min),
and had a SpO2 of 90% on 15 l oxygen; blood pressure
was 100/50 mmHg. Chest examination revealed few
crackles in both mid zones, and a possible chemical/
apsiration pneumonitis was suspected. She had a history of
deliberate self harm. She had no allergies and worked as a
beautician by profession.
Arterial blood gas (ABG) analysis on oxygen showed
pH 7.41 (7.35–7.45), pCO2 3.44 kPa (4.7–6), pO2
31.6 kPa (11–13 on room air), lactate 11.0 (<2), base
excess −7.2 mmol/l (−2–+2) and HCO3 19.4 mmol/l(24–31).
The patient continued to receive high-flow oxygen and
intravenous access was gained, and bloods tests, including
paracetomol and salicylate levels, and a urine toxicology for
the usual drugs of abuse were requested. These subsequently
turned out to be negative. She was treated with intravenous
crystalloids for compensated metabolic acidosis and treated
with antibiotics to cover for aspiration pneumonia. A
differential diagnosis for high anion gap metabolic acidosis
was worked out using the common mnemonic (MUD
PILES—Methanol, Uremia, Diabetic ketoacidosis, Paralde-
hyde, Iron, Lactic acid, Ethanol and ethylene glycol, and
Salicylates, respectively) as the anion gap was 21 (3–11).
Despite her treatment, there was no sign of improvement.
The initial chest x-ray was normal.
A diagnosis of methaemoglobinemia was suspected in
our patient as she demonstrated (1) central cyanosis
The patient gave her written consent for publication of the
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congenital cardiac disease or causes for pulmonary hyper-
tension; (2) decreased oxygen saturation on the pulse
oximeter with a near normal pO2; (3) difference in the
arterial blood gas (95%) and the pulse oximeter (90%)
oxygen saturation measurements; and (4) she was a
beautician with a history of self harm (beauty products
when ingested can result in methaemoglobinaemia). An
urgently requested methaemoglobin (MetHb) level showed
a raised MetHb level (50.3%), which confirmed the
diagnosis. She was subsequently treated with a slow
intravenous dose of methylene blue (2 mg/kg). Clinical
improvement was marked within 20 min. Her tachycardia
and tachypnoea began to settle, and she was now able to
communicate.
Her repeat ABG, 30 min post treatment, showed pH
7.37, pCO2 4.12, pO2 11.6, lactate 6.4, base excess −6.8,
cHCO3 19.2 and MetHb 2.9%. She acknowledged the fact
that she had consumed alcohol but refused to answer the
deliberate self-harm questions. She was observed in a
resuscitation room with regular ABG monitoring through an
arterial line and then transferred to the intensive care unit
where her recovery was complicated by the development of
ARDS. ARDS was confirmed on a CTscan and was thought
to be vasogenic or neurogenic in origin rather than aspiration
or infective. She gradually improved and was eventually
discharged from the hospital about 10 days later. Psychiatric
counselingrevealedthatshehadingestedabarbicide,andout-
patient follow-up including chest clinic was arranged prior to
discharge from the hospital. She was reviewed in the chest
clinic for up to 3 months and had made an excellent recovery
and did not have any ongoing respiratory symptoms, and
hence was discharged from follow-up.
Discussion
Barbicide is a translucent blue disinfectant solution (Fig. 3)
that is used not only in beauty salons to disinfect items such
as combs and scissors, but also in hospitals as it has viricidal,
bactericidal and fungicidal properties [1]. The three impor-
tant ingredients are isopropyl alcohol, sodium nitrite and
dimethyl benzyl ammonium chloride, which result in high
anion gap acidosis, methaemoglobinaemia and normal anion
gap acidosis, respectively, when ingested. Signs and symp-
toms usually start within 30 min after ingestion.
Fig. 2 Peripheral cyanosis
Fig. 1 Facial cyanosis
Fig. 3 Barbicide
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tial diagnosis spectrum in a blue, breathless, acidotic patient
unresponsive to oxygen therapy as it is a potentially fatal,
yet readily treatable condition. A clue to the diagnosis is
bluish discolouration of skin, and the blood has a chocolate
brown colour [2]. The diagnosis can be confirmed by
requesting MetHb levels, which are mostly available in
modern blood gas analysers. The sample should be
analysed very soon after being drawn, as the MetHb level
in the sample will decrease with time.
Haemoglobin (Hb) can accept and transport oxygen only
when the iron atom is in its ferrous form (Fe
2+). When
haemoglobin loses an electron and becomes oxidized, it is
converted to the ferric state (Fe
3+) or MetHb. MetHb lacks
the ability to transport oxygen. The major pathway that
handles 95% of MetHb under physiological conditions is
the Embden-Meyerhoff pathway in which there is an
enzymatic reduction of MetHB to Hb by the enzyme
NADH (nicotinamide adenine dinucleotide) MetHb reduc-
tase [3]. Because red blood cells are continuously exposed
to various oxidant stresses, blood normally contains
approximately 2% MetHb levels [4]. Methemoglobinemia
may be passed down through families (inherited) or
commonly acquired as a result of exposure to certain drugs,
chemicals or foods (acquired). The most commonly
implicated agents include dapsone, local (topical) anaesthe-
tic agents, aniline dyes and nitrates [5]. Anaemic patients
and G6PD-deficient patients are more susceptible to
methaemoglobinaemia.
Differing MetHb levels in blood produce various
symptoms:
& 10–20%, usually asymptomatic despite cyanosis
& 20–30%, headache, dyspnoea and anxiety
& 30–50%, tachycardia, dizziness, palpitaions and fatigue
& 50–70%, acidosis, confusion, coma and seizures
& >70%, fatal.
Use of methylene blue can be life-saving and is
considered the treatment of choice. Methylene blue (MB),
given intravenously in a dose of 1 to 2 mg/kg over 5 min,
usually provides a rapid improvement in the patient’s
condition; the dose may be repeated in 1 h if the level of
MetHb remains high, but retreatment is frequently not
necessary. Contraindications to methylene blue are G6PD
deficiency and renal failure [6]. Supplemental antioxidants
such as ascorbic acid (vitamin C), N-acetylcysteine and
tocopherol (vitamin E) have been used as adjuvants or
alternatives to methylene blue with no confirmed benefit
[7]. Severely affected patients may benefit from adjunctive
treatment with hyperbaric oxygen and/or exchange transfu-
sion, although evidence of their efficacy is only anecdotal
[8,9]. The differential diagnosis is sulfhaemoglobinemia,
which refers to the inclusion of a sulfur molecule into the
heme moiety. This does not respond to methylene blue
treatment [10].
Isopropyl alcohol (IPA) is a colourless liquid with bitter
taste commonly used in deicers and as a sterilising agent in
window cleaners and many disinfectants. It is rapidly
absorbed and reaches peak plasma levels within 30–
60 min. IPA is metabolised by the enzyme alcohol
dehydrogenase to acetone. Alcohols compete with IPA for
this enzyme, and the average half life of IPA can be
prolonged from 4 h to 16 h with co-ingestion of alcohol.
Early clinical features include nausea, vomiting, abdominal
pain, tachycardia, headache and dizziness. Severe poison-
ing can lead to haematemesis, melena, bradycardia,
hypotension, dysrhythmias, hypo- or hyperglycemia, rhab-
domyolysis, renal failure, respiratory depression, convul-
sions and coma. Clinical suspicion is raised by the sweet-
smelling, fruity acetone on the breath. However, raised
anion gap metabolic acidosis on the blood gas with raised
osmolar gap secondary to high serum acetone levels is
strongly suggestive of IPA poisoning [11]. Treatment is
usually supportive, and haemodialysis is rarely needed.
Dimethyl benzyl ammonium chloride (benzalkonium
chloride) is often used as a disinfectant. Clinical features of
ingestion include vomiting, diarrhoea and foaming at the
mouth if the concentration is less than 10%. Higher
concentrations can lead to corrosive damage to the orophar-
ynx and the oesophagus, and should be managed according-
ly. Haematemesis and circulatory collapse can also occur.
Vomiting in the presence of foaming can lead to aspiration,
and the foaming can be minimised with dimeticone.
Conclusion
Acute methaemoglobinemia is usually associated with high
mortality, and an early aggressive treatment with intrave-
nous methylene blue is potentially life-saving. A high level
of suspicion with a relevant history of exposure or ingestion
to a toxin or drug is often the key to the diagnosis.
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